Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masaki Iida

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|April 25, 2017
Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for T2-4N0 tongue cancer: control of occult neck metastasisShuhei Minamiyama, Kenji Mitsudo, Yuichiro Hayashi, et al.
Oral Oncology|March 31, 2018
Chemoradiotherapy using retrograde superselective intra-arterial infusion for tongue cancer: Analysis of therapeutic results in 118 casesKenji Mitsudo, Yuichiro Hayashi, Shuhei Minamiyama, et al.
Radiation Oncology (London, England)|July 5, 2017
Clinical outcomes of retrograde intra-arterial chemotherapy concurrent with radiotherapy for elderly oral squamous cell carcinoma patients aged over 80 years oldYuichiro Hayashi, Kenji Mitsudo, Kaname Sakuma, et al.
Journal of Pharmaceutical Sciences|August 18, 2024
Biowaiver monograph for immediate-release solid oral dosage forms: Raltegravir potassiumAtsushi Kambayashi, Masaki Iida, Makoto Ishihara, et al.
Head & Neck|January 30, 2019
Prognostic factors and treatment outcomes of advanced maxillary gingival squamous cell carcinoma treated by intra-arterial infusion chemotherapy concurrent with radiotherapyYuichiro Hayashi, Kohei Osawa, Rina Nakakaji, et al.
The Open Dentistry Journal|April 21, 2015
Producing Capabilities of Interferon-gamma and Interleukin-10 in Peripheral Blood from Oral Squamous Cell Carcinoma PatientsKosuke Naganawa, Eiji Takayama, Makoto Adachi, et al.
Anticancer Research|October 3, 2014
Increase of peripheral blood CD57+ T-cells in patients with oral squamous cell carcinomaMasaki Iida, Eiji Takayama, Kosuke Naganawa, et al.
Oncotarget|April 13, 2018
Treatment of oral cancer using magnetized paclitaxelRina Nakakaji, Masanari Umemura, Kenji Mitsudo, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|April 25, 2017
Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for T2-4N0 tongue cancer: control of occult neck metastasisShuhei Minamiyama, Kenji Mitsudo, Yuichiro Hayashi, et al.
Oral Oncology|March 31, 2018
Chemoradiotherapy using retrograde superselective intra-arterial infusion for tongue cancer: Analysis of therapeutic results in 118 casesKenji Mitsudo, Yuichiro Hayashi, Shuhei Minamiyama, et al.
Radiation Oncology (London, England)|July 5, 2017
Clinical outcomes of retrograde intra-arterial chemotherapy concurrent with radiotherapy for elderly oral squamous cell carcinoma patients aged over 80 years oldYuichiro Hayashi, Kenji Mitsudo, Kaname Sakuma, et al.
Journal of Pharmaceutical Sciences|August 18, 2024
Biowaiver monograph for immediate-release solid oral dosage forms: Raltegravir potassiumAtsushi Kambayashi, Masaki Iida, Makoto Ishihara, et al.
Head & Neck|January 30, 2019
Prognostic factors and treatment outcomes of advanced maxillary gingival squamous cell carcinoma treated by intra-arterial infusion chemotherapy concurrent with radiotherapyYuichiro Hayashi, Kohei Osawa, Rina Nakakaji, et al.
The Open Dentistry Journal|April 21, 2015
Producing Capabilities of Interferon-gamma and Interleukin-10 in Peripheral Blood from Oral Squamous Cell Carcinoma PatientsKosuke Naganawa, Eiji Takayama, Makoto Adachi, et al.
Anticancer Research|October 3, 2014
Increase of peripheral blood CD57+ T-cells in patients with oral squamous cell carcinomaMasaki Iida, Eiji Takayama, Kosuke Naganawa, et al.
Oncotarget|April 13, 2018
Treatment of oral cancer using magnetized paclitaxelRina Nakakaji, Masanari Umemura, Kenji Mitsudo, et al.
Pageof 2